Hecht Beth

Track

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 26% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Hecht Beth's trades of Xeris Biopharma Holdings Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-04 2026-08-03
PlS Planned sale
62,463 -43.7%
370.42
US$3,960,816 		62,463 -43.7% 370.42 US$3,960,816
2026-07-02 2026-07-01
PlS Planned sale
6,501 +39.5%
449.91
US$1,374,695 		6,501 +39.5% 449.91 US$1,374,695
2026-07-01 2026-07-01
PrS Proposed sale
21,130
179.07
US$4,376,788 		21,130 179.07 US$4,376,788
2026-06-02 2026-06-01
PlS Planned sale
16,667 -1.4%
6.06
US$100,982 		16,667 -1.4% 6.06 US$100,982
2026-05-01 2026-05-01
PlS Planned sale
16,667 -1.4%
6.23
US$103,805 		16,667 -1.4% 6.23 US$103,805
2026-04-03 2026-04-01
PlS Planned sale
16,667 -1.4%
5.99
US$99,859 		16,667 -1.4% 5.99 US$99,859
2026-03-04 2026-03-02
PlS Planned sale
100 -0.0%
7.06
US$706 		100 -0.0% 7.06 US$706
2026-03-04 2026-03-02
PlS Planned sale
16,567 -1.3%
6.24
US$103,380 		16,567 -1.3% 6.24 US$103,380
2026-03-02 2026-03-02
PrS Proposed sale
66,668
6.12
US$408,008 		66,668 6.12 US$408,008
2026-02-02 2026-02-02
PlS Planned sale
16,667 -1.3%
7.45
US$124,147 		16,667 -1.3% 7.45 US$124,147
2026-01-05 2026-01-02
PlS Planned sale
16,667 -1.3%
7.43
US$123,776 		16,667 -1.3% 7.43 US$123,776
2025-12-02 2025-12-01
PlS Planned sale
16,667 -1.2%
7.01
US$116,781 		16,667 -1.2% 7.01 US$116,781
2025-11-13 2025-11-11
PlS Planned sale
16,667 -1.2%
7.40
US$123,296 		16,667 -1.2% 7.40 US$123,296
2025-11-12 2025-11-11
PrS Proposed sale
66,668
7.72
US$514,677 		66,668 7.72 US$514,677
2025-03-21 2025-03-20
S Sale
40,000 -2.9%
5.43
US$217,244 		40,000 -2.9% 5.43 US$217,244
2025-03-20 2025-03-20
PrS Proposed sale
40,000
5.14
US$205,600 		40,000 5.14 US$205,600
2020-03-16 2020-03-13
B Purchase
4,000 +7.5%
1.97
US$7,880 		4,000 +7.5% 1.97 US$7,880
2020-02-18 2020-02-14
B Purchase
4,000 +98.0%
4.15
US$16,600 		4,000 +98.0% 4.15 US$16,600
2019-02-22 2019-02-19
B Purchase
2,500 +inf%
10.00
US$25,000 		2,500 +inf% 10.00 US$25,000